Cynthia Smith Spero Therapeutics, Inc. (SPRO) insider trading activity

SPRO Quotes by TradingView

Cynthia Smith is of Spero Therapeutics, Inc.. Currently has a direct ownership of 55,000 shares of SPRO, which is worth approximately $52,800. The most recent transaction as insider was on May 29, 2024, when has been sold 20,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 55K
0% 3M change
57.14% 12M change
Total Value Held $52,800

Cynthia Smith Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 29 2024
BUY
Grant, award, or other acquisition
-
20,000 Added 26.67%
55,000 Common Stock
Oct 05 2023
BUY
Grant, award, or other acquisition
-
20,000 Added 36.36%
35,000 Common Stock
Sep 15 2022
BUY
Grant, award, or other acquisition
-
15,000 Added 50.0%
15,000 Common Stock

Also insider at

AGIO
AGIOS PHARMACEUTICALS, INC. Healthcare
Director
AKBA
Akebia Therapeutics, Inc. Healthcare
TARA
Protara Therapeutics, Inc. Healthcare
DRNA
Dicerna Pharmaceuticals Inc
Director
CS

Cynthia Smith

Cambridge, MA

Track Institutional and Insider Activities on SPRO

Follow Spero Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SPRO shares.

Notify only if

Insider Trading

Get notified when an Spero Therapeutics, Inc. insider buys or sells SPRO shares.

Notify only if

News

Receive news related to Spero Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on SPRO